Literature DB >> 32371845

Clinical Implementation of Prolonged Liver Preservation and Monitoring Through Normothermic Machine Perfusion in Liver Transplantation.

Benno Cardini1, Rupert Oberhuber1, Margot Fodor1, Theresa Hautz1, Christian Margreiter1, Thomas Resch1, Stefan Scheidl1, Manuel Maglione1, Claudia Bösmüller1, Harald Mair1,2, Marion Frank1,2, Florian Augustin1, Andrea Griesmacher3, Harald Schennach4, Judith Martini2, Robert Breitkopf2, Stephan Eschertzhuber5, Werner Pajk2, Alois Obwegeser6, Herbert Tilg7, Christopher Watson8, Dietmar Öfner1, Annemarie Weissenbacher1, Stefan Schneeberger1.   

Abstract

BACKGROUND: Normothermic machine perfusion (NMP) bears the potential for significant prolongation of liver preservation before transplantation. Although safety and feasibility have been recently published, no data are available describing the significant challenges of establishing NMP programs outside clinical studies. We herein present our experience and propose a multidisciplinary approach for liver NMP in the clinical routine.
METHODS: In February 2018, liver NMP was introduced for routine use in marginal organs, logistic challenges, and complex recipients at our institution. In a multidisciplinary effort among transplant coordinators, perfusionists, transplant surgeons, anesthesia, nurses, blood bank as well as laboratory staff, a clinical routine was established and 34 NMP cases were performed without critical incidents or organ loss.
RESULTS: Nine livers were discarded due to poor organ quality and function observed during NMP. Twenty-five livers were successfully transplanted after preservation of up to 38 h. The extended criteria donors rate was 100% and 92% in discarded and transplanted livers, respectively. Nighttime procedures and parallel transplantations were eventually omitted. Graft and patient survival was 88% at 20 mo. No cholangiopathy was observed despite the use of extended criteria donor organs in 92% of cases.
CONCLUSIONS: NMP in a multidisciplinary approach enables a safe prolongation of liver preservation and overnight organ care. A first field test of NMP indicates safety and benefit of this approach.

Entities:  

Mesh:

Year:  2020        PMID: 32371845     DOI: 10.1097/TP.0000000000003296

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation.

Authors:  Nora Jahn; Maria Theresa Voelker; Sven Laudi; Sebastian Stehr; Stefan Schneeberger; Gerald Brandacher; Elisabeth Sucher; Sebastian Rademacher; Daniel Seehofer; Robert Sucher; Hans Michael Hau
Journal:  J Clin Med       Date:  2022-05-03       Impact factor: 4.964

2.  Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation.

Authors:  Damiano Patrono; Davide Cussa; Federica Rigo; Renato Romagnoli
Journal:  Artif Organs       Date:  2021-09-08       Impact factor: 2.663

3.  A Novel Multidrug Combination Mitigates Rat Liver Steatosis Through Activating AMPK Pathway During Normothermic Machine Perfusion.

Authors:  Min Xu; Fangyu Zhou; Ola Ahmed; Gundumi A Upadhya; Jianluo Jia; Choonghee Lee; Jianwei Xing; Li Ye; So Hee Shim; Zhengyan Zhang; Kathleen Byrnes; Brian Wong; Jae-Sung Kim; Yiing Lin; William C Chapman
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

4.  A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation.

Authors:  Changjun Huang; Zhitao Chen; Tielong Wang; Xiaoshun He; Maogen Chen; Weiqiang Ju
Journal:  Ann Transl Med       Date:  2021-03

Review 5.  Viability Assessment in Liver Transplantation-What Is the Impact of Dynamic Organ Preservation?

Authors:  Rebecca Panconesi; Mauricio Flores Carvalho; Matteo Mueller; David Meierhofer; Philipp Dutkowski; Paolo Muiesan; Andrea Schlegel
Journal:  Biomedicines       Date:  2021-02-07

6.  Reply to 'Hypothermic machine perfusion before viability testing of previously discarded human livers'.

Authors:  Hynek Mergental; Richard W Laing; Simon C Afford; Darius F Mirza
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

7.  Normothermic machine perfusion attenuates hepatic ischaemia-reperfusion injury by inhibiting CIRP-mediated oxidative stress and mitochondrial fission.

Authors:  Wenyan Liu; Yang Fan; Hongfan Ding; Dan Han; Yang Yan; Rongqian Wu; Yi Lv; Xinglong Zheng
Journal:  J Cell Mol Med       Date:  2021-11-16       Impact factor: 5.310

Review 8.  Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs.

Authors:  Christina Bogensperger; Julia Hofmann; Franka Messner; Thomas Resch; Andras Meszaros; Benno Cardini; Annemarie Weissenbacher; Rupert Oberhuber; Jakob Troppmair; Dietmar Öfner; Stefan Schneeberger; Theresa Hautz
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

9.  Dealing With Liver Transplantation during Coronavirus Disease 2019 Pandemic: Normothermic Machine Perfusion Enables for Donor, Organ, and Recipient Assessment: A Case Report.

Authors:  Christina Bogensperger; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Silvia Gasteiger; Valeria Berchtold; Giorgi Otarashvili; Dietmar Öfner; Stefan Schneeberger
Journal:  Transplant Proc       Date:  2020-07-22       Impact factor: 1.066

10.  Ex vivo machine perfusion: current applications and future directions in liver transplantation.

Authors:  Julian Michelotto; Joseph M G V Gassner; Simon Moosburner; Vanessa Muth; Madhukar S Patel; Markus Selzner; Johann Pratschke; Igor M Sauer; Nathanael Raschzok
Journal:  Langenbecks Arch Surg       Date:  2020-11-20       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.